Naturally derived delta-9-tetrahydrocannabinols

For Naturally derived delta-9-tetrahydrocannabinols, schedule is Schedule III; listed under is Hallucinogenic substances; only when is in a U.S. Food and Drug Administration approved product or in marijuana subject to a state medical marijuana license; cfr citation is 21 CFR 1308.13(g)(4), recorded from its source on 2026-09-01.

Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.

What the source says

(4) Naturally derived delta-9-tetrahydrocannabinols in a U.S. Food and Drug Administration approved product or in marijuana subject to a state medical marijuana license—XXXX (i) Naturally derived delta-9-tetrahydrocannabinols means those delta-9-tetrahydrocannabinols, except as in paragraphs (g)(2) and (3) of this section, that are naturally contained in a plant of the genus Cannabis (cannabis plant). (ii) Naturally derived delta-9-tetrahydrocannabinols do not include any material, compound, mixture, or preparation that falls within the definition of hemp set forth in 7 U.S.C. 1639 o. (iii) Naturally derived delta-9-tetrahydrocannabinols do not include any delta-9-tetrahydrocannabinols contained in substances excluded from the definition of marijuana as set forth in 21 U.S.C. 802(16)(B)(ii) .

— ecfr.gov, retrieved 2026-09-01

Where each value comes from

This source states these in separate places, so each value is shown with the passage that states it.

— all from ecfr.gov, retrieved 2026-09-01

Source

• ecfr.govhttps://www.ecfr.gov/current/title-21/chapter-II/part-1308

Last verified against source: 2026-09-01. Due for re-check by 2026-12-30. This page as Markdown · OKF bundle · full dataset as JSON.